Dr. Goldenberg reviews letrozole (Femara) for early breast cancer, lenalidomide (Revlimid) for anemia, and abatacept (Orencia) for rheumatoid arthritis.
You are here
P&T® Journal contents for March 2006
Doctors need help in assisting their patients to understand the new Part D rules. Patients need help to avoid being “scammed.” Dr. Stefanacci helps us sort it out.
The authors discuss the appropriate indications of PPIs and focus on the negative ramifications of the widespread and long-term use of these agents.
Topics covered include therapies for multiple myeloma, leukemia, sickle cell disease, and lymphoma.
The authors report on advances in the treatment of maxillary sinusitis, otitis media, skin and skin structure infections, diarrhea, gram-negative bacterial infections, zygomycosis, infectious mononucleosis, and combination therapy for HIV infection
The essays in “Ethics and the Pharmaceutical Industry” address the complex inter relationships between drug companies, clinicians, patients, and advocacy groups.